The economic burden of depression among adults with rheumatoid arthritis in the United States
- 5 February 2019
- journal article
- research article
- Published by Taylor & Francis Ltd in Journal of Medical Economics
- Vol. 22 (4), 372-378
- https://doi.org/10.1080/13696998.2019.1572015
Abstract
Aims: Depression is the most frequent comorbidity reported among patients with rheumatoid arthritis (RA). Comorbid depression negatively impacts RA patients’ health-related quality-of-life, physical function, mental function, mortality, and experience of pain and symptom severity. The objective of this study was to assess healthcare utilization, expenditures, and work productivity among patients with RA with or without depression. Materials and methods: Data from adult patients who had at least two visits each related to RA and depression over a 1-year period were extracted from the Truven Health MarketScan research databases. Outcomes comprised healthcare resource utilization, work productivity loss, and direct healthcare costs comparing patients with RA with depression (n = 3,478) vs patients with RA without depression (n = 43,222). Results: Patients with RA and depression had a significantly greater relative risk of hospitalization and number of all-cause and RA-related hospitalizations, utilization of emergency services, days spent in the hospital, physician visits, and RA-related surgeries compared with RA patients without depression. Patients with RA and depression had a higher risk of and experienced more events and days of short-term disability compared with patients without depression. The incremental adjusted annual all-cause and RA-related direct costs were $8,488 (95% CI = $6,793–$10,223) and $578 (95% CI = –$98–$1,243), respectively, when comparing patients with RA and depression vs RA only. Limitations: The current analysis is subject to the known limitations of retrospective studies based on administrative claims data. Conclusions: This study suggested increased healthcare utilization, work productivity loss, and economic burden among RA patients due to comorbid depression. These findings emphasize the importance of managing depression and including depression as a factor when devising treatment algorithms for patients with RA.Keywords
Funding Information
- Janssen Research & Development, LLC
This publication has 27 references indexed in Scilit:
- The prevalence of depression in rheumatoid arthritis: a systematic review and meta-analysisRheumatology, 2013
- Work Productivity in Rheumatoid Arthritis: Relationship with Clinical and Radiological FeaturesArthritis, 2012
- Severity of Depression and Magnitude of Productivity LossAnnals of Family Medicine, 2011
- Socioeconomic determinants of disability and depression in patients with rheumatoid arthritisArthritis Care & Research, 2010
- Societal cost of rheumatoid arthritis patients in the USCurrent Medical Research and Opinion, 2009
- Predicting depression in rheumatoid arthritis: The signal importance of pain extent and fatigue, and comorbidityArthritis Care & Research, 2009
- Hidden Cost of Rheumatoid Arthritis (RA): Estimating Cost of Comorbid Cardiovascular Disease and Depression Among Patients with RAThe Journal of Rheumatology, 2009
- Estimates of the prevalence of arthritis and other rheumatic conditions in the United States: Part IArthritis & Rheumatism, 2007
- Understanding the role and significance of gender differences in pain and depression in Chinese elders with osteoarthritisPain, 2007
- Anxiety and depression in patients with rheumatoid arthritisClinical Rheumatology, 2006